Non-Cutaneous Visceral Kaposi's Sarcoma Diagnosis Confounded by Mycobacterium Avium Complex Lymphadenitis

Andrew B Herson; John M Sousou; Kimberly Boldig; Falguni Patel; Pramod Reddy

doi:10.7759/cureus.36765

journal article Mar 27, 2023

Non-Cutaneous Visceral Kaposi's Sarcoma Diagnosis Confounded by Mycobacterium Avium Complex Lymphadenitis

Andrew B Herson John M Sousou Kimberly Boldig Falguni Patel Pramod Reddy

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.36765

Topics

No keywords indexed for this article. Browse by subject →

References

20

[1]

El Mawla Z, Ghannoum H, Saliba M, Michel Minari A, Kanaan HM. Visceral Kaposi’s sarcoma as a presentation in a newly diagnosed HIV-infected man: a case report. Cureus. 2022, 14:e23339. 10.7759/cureus.23339 10.7759/cureus.23339

[2]

Hauser N, McKenzie D, Fonseca X, Orsini J. Visceral Kaposi’s sarcoma presenting as upper gastrointestinal bleeding. Case Rep Gastrointest Med. 2015, 2015:438973. 10.1155/2015/438973 10.1155/2015/438973

[3]

Zeinaty PE, Lebbé C, Delyon J. Endemic Kaposi’s sarcoma. Cancers (Basel). 2023, 15:10.3390/cancers15030872 10.3390/cancers15030872

[4]

Poizot-Martin I, Brégigeon S, Palich R, et al.. Immune reconstitution inflammatory syndrome associated Kaposi sarcoma. Cancers (Basel). 2022, 14:986. 10.3390/cancers14040986 10.3390/cancers14040986

[5]

Falkinham JO. Mycobacterium avium complex: adherence as a way of life. AIMS Microbiol. 2018, 4:428-38. 10.3934/microbiol.2018.3.428 10.3934/microbiol.2018.3.428

[6]

Havlik JA Jr, Horsburgh CR Jr, Metchock B, Williams PP, Fann SA, Thompson SE 3rd. Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. J Infect Dis. 1992, 165:577-80. 10.1093/infdis/165.3.577 10.1093/infdis/165.3.577

[7]

To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. J Clin Med. 2020, 9:2541. 10.3390/jcm9082541 10.3390/jcm9082541

[8]

Corti M, Palmero D. Mycobacterium avium complex infection in HIV/AIDS patients. Expert Rev Anti Infect Ther. 2008, 6:351-63. 10.1586/14787210.6.3.351 10.1586/14787210.6.3.351

[9]

Schulberg S, Al-Feghali V, Bain K, Shehebar J. Non-cutaneous AIDS-associated Kaposi's sarcoma presenting as recurrent rectal abscesses. BMJ Case Rep. 2018, 2018:10.1136/bcr-2018-225749 10.1136/bcr-2018-225749

[10]

Dittmer DP, Damania B. Kaposi’s sarcoma-associated herpesvirus (KSHV)-associated disease in the AIDS patient: an update. Cancer Treat Res. 2019, 177:63-80. 10.1007/978-3-030-03502-0_3 10.1007/978-3-030-03502-0_3

[11]

Vally F, Selvaraj WM, Ngalamika O. Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality. Medicine (Baltimore). 2020, 99:e22415. 10.1097/MD.0000000000022415 10.1097/md.0000000000022415

[12]

Dumic I, Radovanovic M, Igandan O, et al.. A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-Iris) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review. Am J Case Rep. 2020, 21:e926433. 10.12659/AJCR.926433 10.12659/ajcr.926433

[13]

Tesfaye B, Dagne R, Brown K, Horwitz SL. AIDS-related visceral Kaposi sarcoma (KS) presenting with protein-losing enteropathy (PLE). Am J Gastroenterol. 2015, 110:190-1. 10.14309/00000434-201510001-00446

[14]

Nagata N, Shimbo T, Yazaki H, et al.. Predictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity. PLoS One. 2012, 7:e46967. 10.1371/journal.pone.0046967 10.1371/journal.pone.0046967

[15]

Boshoff C. Kaposi's sarcoma biology. IUBMB Life. 2002, 53:259-61. 10.1080/15216540212645 10.1080/15216540212645

[16]

Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013, 137:289-94. 10.5858/arpa.2012-0101-RS 10.5858/arpa.2012-0101-rs

[17]

Donato V, Guarnaccia R, Dognini J, de Pascalis G, Caruso C, Bellagamba R, Morrone A. Radiation therapy in the treatment of HIV-related Kaposi's sarcoma. Anticancer Res. 2013, 33:2153-7.

[18]

Bower M, Palfreeman A, Alfa-Wali M, et al.. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014, 15 Suppl 2:1-92. 10.1111/hiv.12136 10.1111/hiv.12136

[19]

Petre CE, Dittmer DP. Liposomal daunorubicin as treatment for Kaposi's sarcoma. Int J Nanomedicine. 2007, 2:277-88.

[20]

Cianfrocca M, Lee S, Von Roenn J, et al.. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010, 116:3969-77. 10.1002/cncr.25362 10.1002/cncr.25362

Metrics

0

Citations

20

References

Details

Published: Mar 27, 2023

Authors

Department of Materials Science and Engineering, North Carolina State University 1 , Raleigh, North Carolina 27695-7919,; Adroit Materials 2 , 2054 Kildaire Farm Rd., Cary, North Carolina 27518,

Cite This Article

Andrew B Herson, John M Sousou, Kimberly Boldig, et al. (2023). Non-Cutaneous Visceral Kaposi's Sarcoma Diagnosis Confounded by Mycobacterium Avium Complex Lymphadenitis. Cureus. https://doi.org/10.7759/cureus.36765

Non-Cutaneous Visceral Kaposi's Sarcoma Diagnosis Confounded by Mycobacterium Avium Complex Lymphadenitis

You May Also Like